부광미다졸람주사
Recall Summary Bukwang Pharmaceuticals is recalling Bukwang Midazolam Injection due to incorrect labeling on the secondary packaging. The recall affects multiple batches identified by specific barcodes and is classified as a Class II recall. This product was distributed in South Korea.
- Recalling firm
- 부광약품(주)
- Product
- 부광미다졸람주사 (Barcode: 8806422006901, 8806422006918, 8806422006925, 8806422007007, 8806422007014, 8806422007021)
- Reason
- 2차포장표시오기에따른영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-04-02
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/6cbf9676-7d0d-41ed-8abf-24d1952b38f1